Further CEO Share Purchase

Summary by AI BETAClose X

Renalytix plc announced that its Chief Executive Officer, James McCullough, purchased an additional 750 American Depositary Shares (ADS) on February 12, 2026, at an average price of $3.15 per ADS, for a total transaction value of $2,362.50. Following this purchase, Mr. McCullough now holds an interest in 3,430,096 ordinary shares, representing 0.78% of the company's issued share capital. This transaction indicates continued confidence from the CEO in the company's prospects.

Disclaimer*

UK 100

Latest directors dealings